Home
Series of Journals
Literature
Latest literature
Popular literature
About us
Intro
Organizational structure
Job Responsibilities
Copyright
Contact us
The title
The title
The keywords
The author
Wuhan University
Zhongnan Hospital of Wuhan University
Center for Evidence-Based and Translational Medicine of Wuhan University
Home
Results
The title
The title
The keywords
The author
A total of
23
result was found. Results that relate to
Effectiveness
Efficacy and safety of Tislelizumab combined with chemotherapy in the treatment of non-small cell lung cancer: a Meta-analysis
Published on
New Medicine
2025,35(4):442-451.
7204 times
1368 times
WANG Kuan
TAN Xiao
GUO Yanni
Non-small cell lung cancer
Tislelizumab
Chemotherapy
Effectiveness
Safety
Meta-analysis
Details
Pharmacoeconomic evaluation of ribociclib plus fulvestrant in second-line treatment of HR+/HER2- advanced breast cancer for postmenopausal women
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(6):612-620.
7585 times
1149 times
JIA Caifeng
WANG Jie
ZHANG Sen
WANG Meiqi
LI Sainan
WANG Mingxia
Ribociclib
Fulvestrant
Advanced breast cancer
Postmenopausal
Pharmacoeconomic evaluation
Cost-
effectiveness
analysis
Details
Progress of real-world research of the generic and innovator drugs under the national centralized drug procurement policy
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(6):690-701.
11383 times
1435 times
ZHANG Bin
LIU Minna
LI Xiaolin
LI Jinhu
LIU Tianlong
National centralized drug procurement
Real world study
Clinical evaluation
Generic drugs
Innovator drugs
Effectiveness
Safety
Details
Sugemalimab as first-line treatment for non-small cell lung cancer: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(7):806-814.
6426 times
927 times
HOU Yibing
KANG Shuo
GONG Yuan
WANG Xiaohui
NIE Ying
LIU Huanlong
Sugemalimab
Non-small cell lung cancer
Effectiveness
Safety
Economics
Rapid health technology assessment
Details
Tirzepatide in the treatment of type 2 diabetes mellitus: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(9):1057-1065.
7542 times
852 times
ZHANG Yunxuan
ZHOU Haifeng
GAO Ningzhou
WU Jianbo
QIAN Cheng
ZHANG Min
GUO Han
SONG Zhongjuan
LIU Xiaoyan
Tirzepatide
Type 2 diabetes mellitus
Rapid health technology assessment
Efficacy
Safety
Cost-
effectiveness
Details
Inclisiran in the treatment of dyslipidemia: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(10):1198-1205.
3327 times
585 times
CHEN Lingbin
PAN Weiping
CHEN Zhou
XU Wentan
Inclisiran
Dyslipidemia
Efficacy
Safety
Cost-
effectiveness
Rapid health technology assessment
Details
Toripalimab for the treatment of advanced esophageal cancer: a rapid health technology assessment
Published on
Chinese Journal of Pharmacoepidemiology
2025,34(11):1302-1310.
1878 times
360 times
YANG Shou
NIE Ying
GONG Yuan
KANG Shuo
HOU Yibing
WANG Xiaohui
PAN Zhenhua
Toripalimab
Advanced esophageal cancer
Rapid health technology assessment
Effectiveness
Safety
Economy
Details
Application progress of paraben preservatives in pharmaceutical preparations
Published on
Frontiers in Pharmaceutical Sciences
2025,29(12):2145-2153.
1326 times
195 times
YI Qiao
WANG Jie
YAN Leina
Paraben
Antimicrobial
effectiveness
Safety
Methylparaben
Ethylparaben
Bacteriostat
Dosage
Details
上一页
1
2